Determination Of The Key Molecular Mechanisms Affecting The Severity Of Covid-19

 According to the latest research published online on the 24th in the internationally renowned medical journal "Journal of Clinical Research", an enzyme that exists in severe inflammation, sPLA2-IIA, may be the key mechanism leading to the severity of COVID-19 pneumonia. This discovery may provide a new therapeutic target for reducing the mortality rate of COVID-19 pneumonia. At present, the question researchers are investigating is whether this enzyme level is still relatively high and remains active, whether it will be part of the cause of "long-term COVID-19" symptoms.